APO Research
Talk to an analyst

APO RESEARCH · REPORT

Probiotics for Infants and Pregnant Women

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Probiotics for Infants and Pregnant Women Market Outlook and Growth Opportunities 2026

23 December 2025208 pages

Choose your research edition.

Industry ResearchProbiotics for Infants and Pregnant Women Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Probiotics for Infants and Pregnant Women Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Probiotics for Infants and Pregnant Women Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Probiotics for Infants and Pregnant Women Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Probiotics for Infants and Pregnant Women Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Probiotics for Infants and Pregnant Women market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Probiotics for Infants and Pregnant Women is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Probiotics for Infants and Pregnant Women is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Probiotics for Infants and Pregnant Women is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Probiotics for Infants and Pregnant Women market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Probiotics for Infants and Pregnant Women market include Hebei Yiran Biological Technology, Synbio Tech, Morinaga Milk Industry, Nestle, Lallemand, Beijing Scitop Bio-tech, Bioflag Group, DuPont and BioGaia, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Probiotics for Infants and Pregnant Women market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Probiotics for Infants and Pregnant Women and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Probiotics for Infants and Pregnant Women sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Probiotics for Infants and Pregnant Women market size, projected growth trends, production technologies, key applications, and end-use industries.

Probiotics for Infants and Pregnant Women Segment by Company

Hebei Yiran Biological Technology

Synbio Tech

Morinaga Milk Industry

Nestle

Lallemand

Beijing Scitop Bio-tech

Bioflag Group

DuPont

BioGaia

Yakult

Sabinsa

Probi

Novonesis

Kerry Group

Evivo

Biosearch Life

AB-Biotics

Probiotics for Infants and Pregnant Women Segment by Type

Lactobacillus

Bifidobacterium

Others

Probiotics for Infants and Pregnant Women Segment by Application

Online Sales

Offline Sales

Probiotics for Infants and Pregnant Women Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Probiotics for Infants and Pregnant Women status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Probiotics for Infants and Pregnant Women market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Probiotics for Infants and Pregnant Women significant trends, drivers, influence factors in global and regions.

6. To analyze Probiotics for Infants and Pregnant Women competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Probiotics for Infants and Pregnant Women market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Probiotics for Infants and Pregnant Women and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Probiotics for Infants and Pregnant Women.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Probiotics for Infants and Pregnant Women market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Probiotics for Infants and Pregnant Women industry.

Chapter 3: Detailed analysis of Probiotics for Infants and Pregnant Women manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Probiotics for Infants and Pregnant Women in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Probiotics for Infants and Pregnant Women in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Probiotics for Infants and Pregnant Women Industry Trends Table 2. Probiotics for Infants and Pregnant Women Industry Drivers Table 3. Probiotics for Infants and Pregnant Women Industry Opportunities and Challenges Table 4. Probiotics for Infants and Pregnant Women Industry Restraints Table 5. Global Probiotics for Infants and Pregnant Women Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Probiotics for Infants and Pregnant Women Revenue Share by Company (2021-2026) Table 7. Global Probiotics for Infants and Pregnant Women Sales Volume by Company (t) & (2021-2026) Table 8. Global Probiotics for Infants and Pregnant Women Sales Volume Share by Company (2021-2026) Table 9. Global Probiotics for Infants and Pregnant Women Average Price (USD/t) of Company (2021-2026) Table 10. Global Probiotics for Infants and Pregnant Women Company Ranking, (2024-2026) & (USD Million) Table 11. Global Probiotics for Infants and Pregnant Women Key Company Manufacturing Base & Headquarters Table 12. Global Probiotics for Infants and Pregnant Women Company, Product Type & Application Table 13. Global Probiotics for Infants and Pregnant Women Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Probiotics for Infants and Pregnant Women by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Lactobacillus Table 18. Significant Companies of Bifidobacterium Table 19. Significant Companies of Others Table 20. Global Probiotics for Infants and Pregnant Women Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 21. Global Probiotics for Infants and Pregnant Women Sales Volume by Type (2021-2026) & (t) Table 22. Global Probiotics for Infants and Pregnant Women Sales Volume by Type (2027-2032) & (t) Table 23. Global Probiotics for Infants and Pregnant Women Sales Volume Share by Type (2021-2026) Table 24. Global Probiotics for Infants and Pregnant Women Sales Volume Share by Type (2027-2032) Table 25. Global Probiotics for Infants and Pregnant Women Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Probiotics for Infants and Pregnant Women Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Probiotics for Infants and Pregnant Women Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Probiotics for Infants and Pregnant Women Sales Value Share by Type (2021-2026) Table 29. Global Probiotics for Infants and Pregnant Women Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Online Sales Table 31. Significant Companies of Offline Sales Table 32. Global Probiotics for Infants and Pregnant Women Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 33. Global Probiotics for Infants and Pregnant Women Sales Volume by Application (2021-2026) & (t) Table 34. Global Probiotics for Infants and Pregnant Women Sales Volume by Application (2027-2032) & (t) Table 35. Global Probiotics for Infants and Pregnant Women Sales Volume Share by Application (2021-2026) Table 36. Global Probiotics for Infants and Pregnant Women Sales Volume Share by Application (2027-2032) Table 37. Global Probiotics for Infants and Pregnant Women Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Probiotics for Infants and Pregnant Women Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Probiotics for Infants and Pregnant Women Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Probiotics for Infants and Pregnant Women Sales Value Share by Application (2021-2026) Table 41. Global Probiotics for Infants and Pregnant Women Sales Value Share by Application (2027-2032) Table 42. Global Probiotics for Infants and Pregnant Women Sales by Region: 2021 VS 2025 VS 2032 (t) Table 43. Global Probiotics for Infants and Pregnant Women Sales by Region (2021-2026) & (t) Table 44. Global Probiotics for Infants and Pregnant Women Sales Market Share by Region (2021-2026) Table 45. Global Probiotics for Infants and Pregnant Women Sales by Region (2027-2032) & (t) Table 46. Global Probiotics for Infants and Pregnant Women Sales Market Share by Region (2027-2032) Table 47. Global Probiotics for Infants and Pregnant Women Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Probiotics for Infants and Pregnant Women Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Probiotics for Infants and Pregnant Women Sales Value Share by Region (2021-2026) Table 50. Global Probiotics for Infants and Pregnant Women Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Probiotics for Infants and Pregnant Women Sales Value Share by Region (2027-2032) Table 52. Global Probiotics for Infants and Pregnant Women Market Average Price (USD/t) by Region (2021-2026) Table 53. Global Probiotics for Infants and Pregnant Women Market Average Price (USD/t) by Region (2027-2032) Table 54. Global Probiotics for Infants and Pregnant Women Sales by Country: 2021 VS 2025 VS 2032 (t) Table 55. Global Probiotics for Infants and Pregnant Women Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Probiotics for Infants and Pregnant Women Sales by Country (2021-2026) & (t) Table 57. Global Probiotics for Infants and Pregnant Women Sales Market Share by Country (2021-2026) Table 58. Global Probiotics for Infants and Pregnant Women Sales by Country (2027-2032) & (t) Table 59. Global Probiotics for Infants and Pregnant Women Sales Market Share by Country (2027-2032) Table 60. Global Probiotics for Infants and Pregnant Women Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Probiotics for Infants and Pregnant Women Sales Value Market Share by Country (2021-2026) Table 62. Global Probiotics for Infants and Pregnant Women Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Probiotics for Infants and Pregnant Women Sales Value Market Share by Country (2027-2032) Table 64. Hebei Yiran Biological Technology Company Information Table 65. Hebei Yiran Biological Technology Business Overview Table 66. Hebei Yiran Biological Technology Probiotics for Infants and Pregnant Women Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 67. Hebei Yiran Biological Technology Probiotics for Infants and Pregnant Women Product Portfolio Table 68. Hebei Yiran Biological Technology Recent Development Table 69. Synbio Tech Company Information Table 70. Synbio Tech Business Overview Table 71. Synbio Tech Probiotics for Infants and Pregnant Women Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 72. Synbio Tech Probiotics for Infants and Pregnant Women Product Portfolio Table 73. Synbio Tech Recent Development Table 74. Morinaga Milk Industry Company Information Table 75. Morinaga Milk Industry Business Overview Table 76. Morinaga Milk Industry Probiotics for Infants and Pregnant Women Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 77. Morinaga Milk Industry Probiotics for Infants and Pregnant Women Product Portfolio Table 78. Morinaga Milk Industry Recent Development Table 79. Nestle Company Information Table 80. Nestle Business Overview Table 81. Nestle Probiotics for Infants and Pregnant Women Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 82. Nestle Probiotics for Infants and Pregnant Women Product Portfolio Table 83. Nestle Recent Development Table 84. Lallemand Company Information Table 85. Lallemand Business Overview Table 86. Lallemand Probiotics for Infants and Pregnant Women Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 87. Lallemand Probiotics for Infants and Pregnant Women Product Portfolio Table 88. Lallemand Recent Development Table 89. Beijing Scitop Bio-tech Company Information Table 90. Beijing Scitop Bio-tech Business Overview Table 91. Beijing Scitop Bio-tech Probiotics for Infants and Pregnant Women Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 92. Beijing Scitop Bio-tech Probiotics for Infants and Pregnant Women Product Portfolio Table 93. Beijing Scitop Bio-tech Recent Development Table 94. Bioflag Group Company Information Table 95. Bioflag Group Business Overview Table 96. Bioflag Group Probiotics for Infants and Pregnant Women Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 97. Bioflag Group Probiotics for Infants and Pregnant Women Product Portfolio Table 98. Bioflag Group Recent Development Table 99. DuPont Company Information Table 100. DuPont Business Overview Table 101. DuPont Probiotics for Infants and Pregnant Women Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 102. DuPont Probiotics for Infants and Pregnant Women Product Portfolio Table 103. DuPont Recent Development Table 104. BioGaia Company Information Table 105. BioGaia Business Overview Table 106. BioGaia Probiotics for Infants and Pregnant Women Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 107. BioGaia Probiotics for Infants and Pregnant Women Product Portfolio Table 108. BioGaia Recent Development Table 109. Yakult Company Information Table 110. Yakult Business Overview Table 111. Yakult Probiotics for Infants and Pregnant Women Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 112. Yakult Probiotics for Infants and Pregnant Women Product Portfolio Table 113. Yakult Recent Development Table 114. Sabinsa Company Information Table 115. Sabinsa Business Overview Table 116. Sabinsa Probiotics for Infants and Pregnant Women Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 117. Sabinsa Probiotics for Infants and Pregnant Women Product Portfolio Table 118. Sabinsa Recent Development Table 119. Probi Company Information Table 120. Probi Business Overview Table 121. Probi Probiotics for Infants and Pregnant Women Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 122. Probi Probiotics for Infants and Pregnant Women Product Portfolio Table 123. Probi Recent Development Table 124. Novonesis Company Information Table 125. Novonesis Business Overview Table 126. Novonesis Probiotics for Infants and Pregnant Women Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 127. Novonesis Probiotics for Infants and Pregnant Women Product Portfolio Table 128. Novonesis Recent Development Table 129. Kerry Group Company Information Table 130. Kerry Group Business Overview Table 131. Kerry Group Probiotics for Infants and Pregnant Women Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 132. Kerry Group Probiotics for Infants and Pregnant Women Product Portfolio Table 133. Kerry Group Recent Development Table 134. Evivo Company Information Table 135. Evivo Business Overview Table 136. Evivo Probiotics for Infants and Pregnant Women Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 137. Evivo Probiotics for Infants and Pregnant Women Product Portfolio Table 138. Evivo Recent Development Table 139. Biosearch Life Company Information Table 140. Biosearch Life Business Overview Table 141. Biosearch Life Probiotics for Infants and Pregnant Women Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 142. Biosearch Life Probiotics for Infants and Pregnant Women Product Portfolio Table 143. Biosearch Life Recent Development Table 144. AB-Biotics Company Information Table 145. AB-Biotics Business Overview Table 146. AB-Biotics Probiotics for Infants and Pregnant Women Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 147. AB-Biotics Probiotics for Infants and Pregnant Women Product Portfolio Table 148. AB-Biotics Recent Development Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Probiotics for Infants and Pregnant Women Distributors List Table 152. Probiotics for Infants and Pregnant Women Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Probiotics for Infants and Pregnant Women Product Image Figure 2. Global Probiotics for Infants and Pregnant Women Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Probiotics for Infants and Pregnant Women Sales Value (2021-2032) & (US$ Million) Figure 4. Global Probiotics for Infants and Pregnant Women Sales (2021-2032) & (t) Figure 5. Global Probiotics for Infants and Pregnant Women Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Probiotics for Infants and Pregnant Women Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Lactobacillus Image Figure 10. Bifidobacterium Image Figure 11. Others Image Figure 12. Global Probiotics for Infants and Pregnant Women Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 13. Global Probiotics for Infants and Pregnant Women Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Probiotics for Infants and Pregnant Women Sales Volume Share by Type (2021-2032) Figure 15. Global Probiotics for Infants and Pregnant Women Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Probiotics for Infants and Pregnant Women Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Probiotics for Infants and Pregnant Women Sales Value Share by Type (2021-2032) Figure 18. Online Sales Image Figure 19. Offline Sales Image Figure 20. Global Probiotics for Infants and Pregnant Women Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 21. Global Probiotics for Infants and Pregnant Women Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Probiotics for Infants and Pregnant Women Sales Volume Share by Application (2021-2032) Figure 23. Global Probiotics for Infants and Pregnant Women Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Probiotics for Infants and Pregnant Women Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Probiotics for Infants and Pregnant Women Sales Value Share by Application (2021-2032) Figure 26. Global Probiotics for Infants and Pregnant Women Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 27. Global Probiotics for Infants and Pregnant Women Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Probiotics for Infants and Pregnant Women Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Probiotics for Infants and Pregnant Women Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Probiotics for Infants and Pregnant Women Sales Value (2021-2032) & (US$ Million) Figure 31. North America Probiotics for Infants and Pregnant Women Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Probiotics for Infants and Pregnant Women Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Probiotics for Infants and Pregnant Women Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Probiotics for Infants and Pregnant Women Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Probiotics for Infants and Pregnant Women Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Probiotics for Infants and Pregnant Women Sales Value (2021-2032) & (US$ Million) Figure 37. South America Probiotics for Infants and Pregnant Women Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Probiotics for Infants and Pregnant Women Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Probiotics for Infants and Pregnant Women Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Probiotics for Infants and Pregnant Women Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Probiotics for Infants and Pregnant Women Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Lactobacillus
  • Bifidobacterium
  • Others
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Hebei Yiran Biological Technology
  • Synbio Tech
  • Morinaga Milk Industry
  • Nestle
  • Lallemand
  • Beijing Scitop Bio-tech
  • Bioflag Group
  • DuPont
  • BioGaia
  • Yakult
  • Sabinsa
  • Probi
  • Novonesis
  • Kerry Group
  • Evivo
  • Biosearch Life
  • AB-Biotics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Probiotics for Infants and Pregnant Women Sales Value (2021-2032)
  4. 1.2.2 Global Probiotics for Infants and Pregnant Women Sales Volume (2021-2032)
  5. 1.2.3 Global Probiotics for Infants and Pregnant Women Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Probiotics for Infants and Pregnant Women Market Dynamics
  1. 2.1 Probiotics for Infants and Pregnant Women Industry Trends
  2. 2.2 Probiotics for Infants and Pregnant Women Industry Drivers
  3. 2.3 Probiotics for Infants and Pregnant Women Industry Opportunities and Challenges
  4. 2.4 Probiotics for Infants and Pregnant Women Industry Restraints
3 Probiotics for Infants and Pregnant Women Market by Company
  1. 3.1 Global Probiotics for Infants and Pregnant Women Company Revenue Ranking in 2025
  2. 3.2 Global Probiotics for Infants and Pregnant Women Revenue by Company (2021-2026)
  3. 3.3 Global Probiotics for Infants and Pregnant Women Sales Volume by Company (2021-2026)
  4. 3.4 Global Probiotics for Infants and Pregnant Women Average Price by Company (2021-2026)
  5. 3.5 Global Probiotics for Infants and Pregnant Women Company Ranking (2024-2026)
  6. 3.6 Global Probiotics for Infants and Pregnant Women Company Manufacturing Base and Headquarters
  7. 3.7 Global Probiotics for Infants and Pregnant Women Company Product Type and Application
  8. 3.8 Global Probiotics for Infants and Pregnant Women Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Probiotics for Infants and Pregnant Women Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Probiotics for Infants and Pregnant Women Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Probiotics for Infants and Pregnant Women Market by Type
  1. 4.1 Probiotics for Infants and Pregnant Women Type Introduction
  2. 4.1.1 Lactobacillus
  3. 4.1.2 Bifidobacterium
  4. 4.1.3 Others
  5. 4.2 Global Probiotics for Infants and Pregnant Women Sales Volume by Type
  6. 4.2.1 Global Probiotics for Infants and Pregnant Women Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Probiotics for Infants and Pregnant Women Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Probiotics for Infants and Pregnant Women Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Probiotics for Infants and Pregnant Women Sales Value by Type
  10. 4.3.1 Global Probiotics for Infants and Pregnant Women Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Probiotics for Infants and Pregnant Women Sales Value by Type (2021-2032)
  12. 4.3.3 Global Probiotics for Infants and Pregnant Women Sales Value Share by Type (2021-2032)
5 Probiotics for Infants and Pregnant Women Market by Application
  1. 5.1 Probiotics for Infants and Pregnant Women Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Probiotics for Infants and Pregnant Women Sales Volume by Application
  5. 5.2.1 Global Probiotics for Infants and Pregnant Women Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Probiotics for Infants and Pregnant Women Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Probiotics for Infants and Pregnant Women Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Probiotics for Infants and Pregnant Women Sales Value by Application
  9. 5.3.1 Global Probiotics for Infants and Pregnant Women Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Probiotics for Infants and Pregnant Women Sales Value by Application (2021-2032)
  11. 5.3.3 Global Probiotics for Infants and Pregnant Women Sales Value Share by Application (2021-2032)
6 Probiotics for Infants and Pregnant Women Regional Sales and Value Analysis
  1. 6.1 Global Probiotics for Infants and Pregnant Women Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Probiotics for Infants and Pregnant Women Sales by Region (2021-2032)
  3. 6.2.1 Global Probiotics for Infants and Pregnant Women Sales by Region: 2021-2026
  4. 6.2.2 Global Probiotics for Infants and Pregnant Women Sales by Region (2027-2032)
  5. 6.3 Global Probiotics for Infants and Pregnant Women Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Probiotics for Infants and Pregnant Women Sales Value by Region (2021-2032)
  7. 6.4.1 Global Probiotics for Infants and Pregnant Women Sales Value by Region: 2021-2026
  8. 6.4.2 Global Probiotics for Infants and Pregnant Women Sales Value by Region (2027-2032)
  9. 6.5 Global Probiotics for Infants and Pregnant Women Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Probiotics for Infants and Pregnant Women Sales Value (2021-2032)
  12. 6.6.2 North America Probiotics for Infants and Pregnant Women Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Probiotics for Infants and Pregnant Women Sales Value (2021-2032)
  15. 6.7.2 Europe Probiotics for Infants and Pregnant Women Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Probiotics for Infants and Pregnant Women Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Probiotics for Infants and Pregnant Women Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Probiotics for Infants and Pregnant Women Sales Value (2021-2032)
  21. 6.9.2 South America Probiotics for Infants and Pregnant Women Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Probiotics for Infants and Pregnant Women Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Probiotics for Infants and Pregnant Women Sales Value Share by Country, 2025 VS 2032
7 Probiotics for Infants and Pregnant Women Country-level Sales and Value Analysis
  1. 7.1 Global Probiotics for Infants and Pregnant Women Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Probiotics for Infants and Pregnant Women Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Probiotics for Infants and Pregnant Women Sales by Country (2021-2032)
  4. 7.3.1 Global Probiotics for Infants and Pregnant Women Sales by Country (2021-2026)
  5. 7.3.2 Global Probiotics for Infants and Pregnant Women Sales by Country (2027-2032)
  6. 7.4 Global Probiotics for Infants and Pregnant Women Sales Value by Country (2021-2032)
  7. 7.4.1 Global Probiotics for Infants and Pregnant Women Sales Value by Country (2021-2026)
  8. 7.4.2 Global Probiotics for Infants and Pregnant Women Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Probiotics for Infants and Pregnant Women Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Probiotics for Infants and Pregnant Women Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Probiotics for Infants and Pregnant Women Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Hebei Yiran Biological Technology
  2. 8.1.1 Hebei Yiran Biological Technology Company Information
  3. 8.1.2 Hebei Yiran Biological Technology Business Overview
  4. 8.1.3 Hebei Yiran Biological Technology Probiotics for Infants and Pregnant Women Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Hebei Yiran Biological Technology Probiotics for Infants and Pregnant Women Product Portfolio
  6. 8.1.5 Hebei Yiran Biological Technology Recent Developments
  7. 8.2 Synbio Tech
  8. 8.2.1 Synbio Tech Company Information
  9. 8.2.2 Synbio Tech Business Overview
  10. 8.2.3 Synbio Tech Probiotics for Infants and Pregnant Women Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Synbio Tech Probiotics for Infants and Pregnant Women Product Portfolio
  12. 8.2.5 Synbio Tech Recent Developments
  13. 8.3 Morinaga Milk Industry
  14. 8.3.1 Morinaga Milk Industry Company Information
  15. 8.3.2 Morinaga Milk Industry Business Overview
  16. 8.3.3 Morinaga Milk Industry Probiotics for Infants and Pregnant Women Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Morinaga Milk Industry Probiotics for Infants and Pregnant Women Product Portfolio
  18. 8.3.5 Morinaga Milk Industry Recent Developments
  19. 8.4 Nestle
  20. 8.4.1 Nestle Company Information
  21. 8.4.2 Nestle Business Overview
  22. 8.4.3 Nestle Probiotics for Infants and Pregnant Women Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Nestle Probiotics for Infants and Pregnant Women Product Portfolio
  24. 8.4.5 Nestle Recent Developments
  25. 8.5 Lallemand
  26. 8.5.1 Lallemand Company Information
  27. 8.5.2 Lallemand Business Overview
  28. 8.5.3 Lallemand Probiotics for Infants and Pregnant Women Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Lallemand Probiotics for Infants and Pregnant Women Product Portfolio
  30. 8.5.5 Lallemand Recent Developments
  31. 8.6 Beijing Scitop Bio-tech
  32. 8.6.1 Beijing Scitop Bio-tech Company Information
  33. 8.6.2 Beijing Scitop Bio-tech Business Overview
  34. 8.6.3 Beijing Scitop Bio-tech Probiotics for Infants and Pregnant Women Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Beijing Scitop Bio-tech Probiotics for Infants and Pregnant Women Product Portfolio
  36. 8.6.5 Beijing Scitop Bio-tech Recent Developments
  37. 8.7 Bioflag Group
  38. 8.7.1 Bioflag Group Company Information
  39. 8.7.2 Bioflag Group Business Overview
  40. 8.7.3 Bioflag Group Probiotics for Infants and Pregnant Women Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bioflag Group Probiotics for Infants and Pregnant Women Product Portfolio
  42. 8.7.5 Bioflag Group Recent Developments
  43. 8.8 DuPont
  44. 8.8.1 DuPont Company Information
  45. 8.8.2 DuPont Business Overview
  46. 8.8.3 DuPont Probiotics for Infants and Pregnant Women Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 DuPont Probiotics for Infants and Pregnant Women Product Portfolio
  48. 8.8.5 DuPont Recent Developments
  49. 8.9 BioGaia
  50. 8.9.1 BioGaia Company Information
  51. 8.9.2 BioGaia Business Overview
  52. 8.9.3 BioGaia Probiotics for Infants and Pregnant Women Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 BioGaia Probiotics for Infants and Pregnant Women Product Portfolio
  54. 8.9.5 BioGaia Recent Developments
  55. 8.10 Yakult
  56. 8.10.1 Yakult Company Information
  57. 8.10.2 Yakult Business Overview
  58. 8.10.3 Yakult Probiotics for Infants and Pregnant Women Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Yakult Probiotics for Infants and Pregnant Women Product Portfolio
  60. 8.10.5 Yakult Recent Developments
  61. 8.11 Sabinsa
  62. 8.11.1 Sabinsa Company Information
  63. 8.11.2 Sabinsa Business Overview
  64. 8.11.3 Sabinsa Probiotics for Infants and Pregnant Women Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sabinsa Probiotics for Infants and Pregnant Women Product Portfolio
  66. 8.11.5 Sabinsa Recent Developments
  67. 8.12 Probi
  68. 8.12.1 Probi Company Information
  69. 8.12.2 Probi Business Overview
  70. 8.12.3 Probi Probiotics for Infants and Pregnant Women Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Probi Probiotics for Infants and Pregnant Women Product Portfolio
  72. 8.12.5 Probi Recent Developments
  73. 8.13 Novonesis
  74. 8.13.1 Novonesis Company Information
  75. 8.13.2 Novonesis Business Overview
  76. 8.13.3 Novonesis Probiotics for Infants and Pregnant Women Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Novonesis Probiotics for Infants and Pregnant Women Product Portfolio
  78. 8.13.5 Novonesis Recent Developments
  79. 8.14 Kerry Group
  80. 8.14.1 Kerry Group Company Information
  81. 8.14.2 Kerry Group Business Overview
  82. 8.14.3 Kerry Group Probiotics for Infants and Pregnant Women Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Kerry Group Probiotics for Infants and Pregnant Women Product Portfolio
  84. 8.14.5 Kerry Group Recent Developments
  85. 8.15 Evivo
  86. 8.15.1 Evivo Company Information
  87. 8.15.2 Evivo Business Overview
  88. 8.15.3 Evivo Probiotics for Infants and Pregnant Women Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Evivo Probiotics for Infants and Pregnant Women Product Portfolio
  90. 8.15.5 Evivo Recent Developments
  91. 8.16 Biosearch Life
  92. 8.16.1 Biosearch Life Company Information
  93. 8.16.2 Biosearch Life Business Overview
  94. 8.16.3 Biosearch Life Probiotics for Infants and Pregnant Women Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Biosearch Life Probiotics for Infants and Pregnant Women Product Portfolio
  96. 8.16.5 Biosearch Life Recent Developments
  97. 8.17 AB-Biotics
  98. 8.17.1 AB-Biotics Company Information
  99. 8.17.2 AB-Biotics Business Overview
  100. 8.17.3 AB-Biotics Probiotics for Infants and Pregnant Women Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 AB-Biotics Probiotics for Infants and Pregnant Women Product Portfolio
  102. 8.17.5 AB-Biotics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Probiotics for Infants and Pregnant Women Value Chain Analysis
  2. 9.1.1 Probiotics for Infants and Pregnant Women Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Probiotics for Infants and Pregnant Women Sales Mode & Process
  6. 9.2 Probiotics for Infants and Pregnant Women Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Probiotics for Infants and Pregnant Women Distributors
  9. 9.2.3 Probiotics for Infants and Pregnant Women Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst